Forbright director Flanders acquires 1,078 stock units

The deferred units will settle in shares following the director’s termination of board service.

Rhea-AI Filing Summary

Forbright, Inc. director Cynthia Flanders acquired 1,078 fully vested deferred restricted stock units (DRSUs) on October 15, 2026, in lieu of her quarterly cash retainer fee. Each DRSU represents a contingent right to receive one share of Class A common stock and will settle in shares following termination of her board service. Her reported total following the transaction was 21,319 shares.

Insider Trade Summary

Grant/Award: 1,078 shares

Grant/Award 1 txn

Insider Flanders Cynthia

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Class A Common Stock F1	1,078	$17.39	$19K

Holdings After Transaction: Class A Common Stock — 21,319 shares (Direct)

Footnotes (1)

1. F1. Represents fully vested deferred restricted stock units ("DRSUs") granted in lieu of the Reporting Person's quarterly cash retainer fee, which will settle in shares following the termination of the Reporting Person's service as a member of the Issuer's board of directors. Each DRSU represents a contingent right to receive one share of Class A common stock.

Key Figures

DRSUs acquired: 1,078 DRSUs Reported per-share amount: $17.39 per share Reported total following transaction: 21,319 shares +1 more

4 metrics

DRSUs acquired 1,078 DRSUs Granted October 15, 2026, in lieu of the quarterly cash retainer fee

Reported per-share amount $17.39 per share Associated with the DRSU acquisition

Reported total following transaction 21,319 shares Direct position after the transaction

Shares per DRSU 1 share Each DRSU represents a contingent right to receive one share of Class A common stock

Key Terms

deferred restricted stock units (DRSUs), contingent right, settle in shares

3 terms

deferred restricted stock units (DRSUs) financial

"fully vested deferred restricted stock units ("DRSUs") granted"

contingent right financial

"Each DRSU represents a contingent right to receive one share"

settle in shares financial

"will settle in shares following the termination"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many DRSUs did Forbright director Cynthia Flanders receive?

Cynthia Flanders received 1,078 DRSUs on October 15, 2026, in lieu of her quarterly cash retainer fee.

What per-share amount did Forbright report for Cynthia Flanders’s DRSU grant?

The transaction data reports a per-share amount of $17.39 for the acquisition of 1,078 DRSUs.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 10/19/2026 - 04:08 PM EDT Accepted by SEC EDGAR 10/19/2026 - 04:08 PM EDT Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Flanders Cynthia

(Last) (First) (Middle)

4445 WILLARD AVENUE

SUITE 1000

(Street)

CHEVY CHASE MARYLAND 20815

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Forbright, Inc. [ FRBT ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
10/15/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Class A Common Stock	10/15/2026		A		1,078(1)	A	$17.39	21,319	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Represents fully vested deferred restricted stock units ("DRSUs") granted in lieu of the Reporting Person's quarterly cash retainer fee, which will settle in shares following the termination of the Reporting Person's service as a member of the Issuer's board of directors. Each DRSU represents a contingent right to receive one share of Class A common stock.

Remarks:

	/s/ Randi Killen, as attorney-in-fact	10/19/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)